StockData
Jupiter Neurosciences, Inc. logo

Jupiter Neurosciences, Inc. (JUNS) stock

JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$1.52−0.18 (-10.59%)

Close on Nov 17, 2026Market cap $1.17MP/E –Yield –

Jupiter Neurosciences total assets

Total assets on the balance sheet at the end of each period.

Jupiter Neurosciences's total assets was $3.72M at Jun 30, 2026. For fiscal 2025 it was $5.56M, down 10.3% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.56M-10.3%
FY2024Dec 31, 2024$6.20M+4074.1%
FY2023Dec 31, 2023$148.59K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.72M-6.3%
Q1 FY2026Mar 31, 2026$3.95M-20.4%
Q4 FY2025Dec 31, 2025$5.56M-10.3%
Q3 FY2025Sep 30, 2025$2.58M+2911.5%
Q2 FY2025Jun 30, 2025$3.97M+2570.5%
Q1 FY2025Mar 31, 2025$4.96M–
Q4 FY2024Dec 31, 2024$6.20M–
Q3 FY2024Sep 30, 2024$85.55K–
Q4 FY2023Dec 31, 2023$148.59K–

More Jupiter Neurosciences figures

See a number that looks wrong?